Accurate Machine Learning Algorithm for Monkey Pox Based on Covid-19

The Covid-19 virus is still marching all over the world. Many people are getting infected and a few are fatal to death. This research paper expressed that supervised learning has revealed supreme results than unsupervised learning in machine learning. Within supervised learning, random forest regression outplays all other algorithms like logistic regression (LR), support vector machine (SVM), decision tree (DT), etc. Now monkeypox is escalating in other countries at present. This virus is allied to human orthopox viruses. It can expand from one to one through contact person having rash or body fluids etc. The symptoms of monkeypox are much similar to covid19 virus-like fever, cold, fatigue, and body pains. Herewith we concluded that random forest regression shows possible foremost (97.15%) accuracy. © 2023 IEEE.

A Review on Recent Monkey Pox Outbreak in 2022

Monkey pox, a zoonotic disease with clinical symptoms resembling smallpox, unexpectedly broke out and spread over the world after the outbreak of COVID-19, severely affecting several of the continents of the world. Monkey pox is currently a member of the genus otrhopox virus, which is a member of the sub family chorodoxvirinae. According to the available knowledge, small mammals and rodents have all been identified as potential sources of the monkey [ox virus]. The disease is characterized by a short febrile illness with lymphadenopathy followed by a rash which spreads centrifugally and passes through phases of macules, papules, vesicles, and pustules. Recovery occurs in most patients within 2-4 wk. Complications are more likely in children, pregnant women, and the immunocompromised. Specific diagnosis is by detection of viral DNA by PCR.Tecovirimat, brincidofovir, and cidofoviir are the medications used to treat monkey pox, immunoglobulin and new compounds are the vaccinations. This review will introduce a general overview of MPXV and describe the epidemiology, clinical features, evaluation, and treatment of monkey pox patients.Copyright © Journal of Global Trends in Pharmaceutical Sciences.

Monkeypox Virus and Other Emerging Outbreaks: An Overview and Future Perspective.

Monkeypox (MPX) is a zoonotic disease caused by the MPX virus from the poxviridae family of orthopoxviruses. Typically, endemic in central and west Africa, it has now become a matter of concern since cases have been reported in non-endemic countries around mid-June 2022, especially in the European region, with the transmission not related to travel. The diagnosis is made by PCR testing of the skin lesions. Even though treatment is symptomatic, antiretrovirals, such as tecovirimat, are used in severe cases. Vaccination with second and third generation vaccines is approved for prophylaxis in high risk individuals. Unfortunately, these options of treatment and prevention are only available in high income countries at the moment. This review, through a thorough literature search of articles from 2017 onward, focuses on epidemiology, clinical manifestations, challenges, treatment, prevention and control of MPX virus and how they can be corelated with other viral outbreaks including COVID-19, Acute Hepatitis of unknown origin, Measles and Dengue, to better predict and therefore prevent its transmission. The previous COVID-19 pandemic increased the disease burden on healthcare infrastructure of low-middle income countries, therefore, this recent MPX outbreak calls for a joint effort from healthcare authorities, political figures, and NGOs to combat the disease and prevent its further spread not only in high income but also in middle- and low-income countries.

Performance Analysis of Machine Learning Classification Approaches for Monkey Pox Disease Prediction

After covid-19 pandemic, many countries have the possibility of getting affected by Monkey Pox Virus. Monkey pox has the same symptoms of smallpox, chicken pox, and measles virus. In this work, the computational models are construed to predict the presence or absence of monkey pox virus. Eight different Classification algorithms including Decision Tree (DT), Random Forest Classification (RF), Naïve Bayes (NB), K-Nearest Neighbor algorithms (KNN), Support Vector Machine (SVM), Logistic Regression (LR), Ada Boosting algorithm (AB), Gradient Boosting (GB) algorithm are used for the Classification of Monkey Pox disease. Four evaluation measures are used in this work to compute the accuracy of classification. Four measures F-Score, Accuracy, Precision, and Recall are used to compare the eight different types of classification algorithms. Based on experimental analysis, it was observed that highest accuracy of 71% is achieved by Gradient Boosting algorithm when compared to other algorithms. © 2022 IEEE.

Deep Learning Methods for Early Detection of Monkeypox Skin Lesion

As the world has not fully recovered from the aftermath of COVID-19, a new pandemic appears on the horizon. Monkey Pox is emerging as a new threat to the health of the world population. With the recorded spread over 40 countries worldwide it might be soon declared a pandemic. Monkey Pox shares common features with chickenpox and measles making it difficult to diagnose. Developing a new test kit at this early stage is a challenging task for the medical fraternity. This paper proposes the use of deep learning models that can be used to make the process of diagnosis automated. This paper tries to come up with a performance comparison of ResNet50, EfficientNetB3 and EfficientNetB7 algorithms. This study suggests a method for early detection of Monkey Pox Skin Lesion. Though an extensive study with other models on a larger dataset containing more images from various countries of the world needs to be carried out but this study gives some promising results on this limited dataset. © 2022 IEEE.

The 2022 Monkeypox Epidemic and What Has Led to the Current State of the Disease in the US: A Systematic Review.

Monkeypox virus (MPOX) is a zoonotic disease in humans. It is similar genetically to its virus family member, smallpox. This virus has been studied since the 1970s. The virus remains endemic to the Congo and West African regions, but non-endemic spreads have been cited. The most recent non-endemic outbreak in the spring of 2022 amidst the current COVID-19 pandemic is of interest due to its impact on global medical, economic, and societal climates. This literature review aims to highlight the virology, clinical signs and symptoms, diagnosis, prevention, and treatment of MPOX and discuss the social implications of the recent 2022 outbreak. We hope this review can pinpoint important clinical pearls of the MPOX virus and its societal impacts to further promote important discussion of this virus and its disease.

A perspective influence of the Epsilon variant of COVID-19 on Catechol-O-Methyltransferase Val158Met leads to the emergence of human papilloma virus-Gueye, which is wrongly described as monkey pox

A perspective study discussed how the epsilon variant of COVID-19 induced mutation to the existed human papilloma virus via mutagenic cadmium content of the COVID-19, and arsenic content of epsilon variant lead to appearance of new strain of human papilloma virus, we named it Human Papilloma Virus-Gueye. As this virus is most common among gay men, and due to the absence of infection with it among HIV-controlled patients. We suggest that this virus disturbs Catechol-O-Methyltransferase Val158Met which is the region which is responsible for male sexual orientation and has been linked to executive dysfunction, which might increase sexual risk behaviours favouring HIV transmission, which is damaged by mycotoxin of myecetoma fungal species and by cadmium contents of epsilon variant of COVID-19. We conclude that COVID-19 is not hazardous just because of its severe symptoms, but also because of its action as a mutagen on other microbes that may be present in a subclinical state. Also, we suggest that immunization against COVID-19 may lead to unexpected complications, especially mutations in other microbes. Finally, we claim that the scientific community named it monkey pox. Even among individuals who do not travel to the endemic, it is just mutant form of Human Papilloma virus.

Monkeypox virus: Future role in Human population.

BACKGROUND: Monkeypox viral infection is considered as global public health and a rare disease caused by Monkeypox virus (MPXV), which is caused by smallpox-like virus and it causes pustules all over the body. MPV is an emerging zoonotic infection with sporadic occurrence globally and multiple outbreaks have been reported in African regions. The story of MPXV has been started since 1970 in Democratic republic of Cargo. The high cases of MPXV was majorly detected in Congo Rain Forest region in Africa. Animal-human (Zoonotic) transmission occurred, although the individual infected animal was not recognized. Human-human transmission occurs and is difficult until bodily fluids or respiratory droplets are exchanged. If a specific individual uses an infected person's towels or bed sheets, infection may occur. AIM: The aim of this review is to document the methods of diagnosis, treatments (vaccines) and future role of MPXV in human population. OUTPUT: The diagnosis is confirmed mainly through clinical diagnosis and then laboratory diagnosis such as cell-culture, serological and Polymerase Chain Reaction tests. Presently, there is no vaccine for MPXV but the smallpox vaccine will protect. The old vaccine includes antivirals approved for use against Orthopoxvirus, such as tecovirimat, which can treat up to 85 % of MPXV in humans. MPXV is now considered as transmission virus which affects from human to humans. The fatality rate was documented to be 3-10 % in children and in adults it is very low. CONCLUSION: This review concludes MPXV is not as contagious as COVID-19 but proper measures should be taken as mentioned in this review to avoid MPXV. Presently, controlling MPXV presents unique challenges, and future prospective global studies in antivirals for this disease, as well as an MPXV vaccines, are recommended to eliminate this virus.

Monkeypox outbreak amidst COVID-19 reemergence in the European Region: Challenges, efforts, and recommendations.

Monkeypox (MPX), caused by the Monkeypox virus (MPXV), is an endemic disease in African countries and is currently causing outbreaks in several European regions, amidst a recent surge in new COVID-19 cases. This can significantly impact already exhausted healthcare services, adding on to the economic and social burdens in the region. A lack of sufficient laboratory diagnostics, antivirals, vaccines may hinder effective clinical management of affected patients. Therefore, it is essential to increase awareness about MPX and its transmission among the general population, to ensure necessary precautions are taken and new cases are reported swiftly. This article discusses the impact of MPXV on the current reemergence of COVID-19 in Europe, lessons learnt during the COVID-19 pandemic and recommendations to address potential challenges.